The American Diabetes Association Debuts the 85th Scientific Sessions with Breakthrough Diabetes Research

Premier Diabetes Meeting to Feature Cutting-Edge Data on Obesity, Emerging Technologies, the Innovation Challenge, and the Latest Advances in Diabetes Treatment

CHICAGO, June 10, 2025 /PRNewswire/ -- From June 20–23, the American Diabetes Association^® (ADA) will host the 85^th Scientific Sessions in Chicago. The ADA's Scientific Sessions is the world's largest diabetes meeting, convening more than 11,000 attendees from around the globe to share cutting-edge scientific discoveries and advancements in diabetes care and innovation. This year's Scientific Sessions will commemorate the extraordinary advancements in diabetes knowledge, treatment, and care that have occurred during the ADA's 85 years, recognizing that every new bit of knowledge, every advancement in treatment—it all matters. This milestone year will be marked at the premier diabetes meeting, held in person at the McCormick Place Convention Center and available on demand from June 25–August 25.

Over 38 million children and adults in the U.S. are living with diabetes, and nearly 98 million American adults are living with prediabetes. That's nearly one in two Americans living with diabetes or prediabetes. And of those living with prediabetes, 81% of them don't know they have it.

Among the key themes at the Scientific Sessions, you can expect:

• Transforming treatment and care for diabetes, obesity, and more: Roughly 42% (109.9 million) of American adults are living with obesity. In fact, obesity is linked to 30–53% of new diabetes cases in the U.S. yearly and continues to rise.
  
  This year's meeting will showcase a range of cutting-edge clinical studies highlighting innovations in obesity care and treatment, emerging standards of care, and groundbreaking data on GLP-1-based medications. These findings will explore the broader impact on overall health, including cardiovascular outcomes, peripheral artery disease, and weight loss.

• Beta cell therapy: Innovative technologies and scientific breakthroughs in beta cell therapy—particularly for type 1 diabetes—are advancing efforts to replace or regenerate the pancreatic beta cells responsible for insulin production. Upcoming studies will spotlight these cutting-edge developments in the field.
  
  
• Technology and innovation: Innovative technologies and solutions are always transforming the diabetes space, offering new possibilities. Studies will highlight advancements in predictive modeling and machine learning algorithms to improve outcomes in patient care.
  
  On Saturday, June 21, from 4:30–6:00 p.m. CT, the Innovation Challenge, which debuted in 2023, invites emerging companies to pitch novel ideas to improve the lives of people living with diabetes. A panel of judges, with input from a live audience, will determine which contestants earn a private meeting with potential funders.

• Patient perspective: Join the ADA's CEO, Charles "Chuck" Henderson, for a powerful conversation with Emmy- and Golden Globes-nominated actor and Diabetes Advocate, Anthony Anderson. Anthony will share his personal journey and how work in research, prevention, and care inspires hope for the future.

"As we kick off the 85^th Scientific Sessions, we're proud to present a program that highlights our ongoing commitment to tackling the complex challenges of diabetes," said Rita Rastogi Kalyani, MD, MHS, the ADA's president of medicine and science. "This year's agenda showcases our dedication to pushing the boundaries of research, encouraging innovation, and ultimately enhancing the lives of people living with diabetes and obesity. We anticipate a dynamic and meaningful event that will inspire progress and shape the future of diabetes care, especially during this critical era of therapeutic and technological breakthroughs."

Other notable topics and themes highlighted in the presentations at the 85^th Scientific Sessions include maternal health, weight management, effects of diet beverages, prevention, and early risk monitoring.

"This year's Scientific Sessions will showcase cutting-edge advancements in diabetes research through a robust, data-focused program," said Mark Atkinson, PhD, chair of the 85^th Scientific Sessions Planning Committee. "Whether attending in person or watching on-demand, participants will have the chance to connect with top experts, take part in engaging discussions, and gain critical insights that will help shape the future of diabetes care."

Learn more about the 85^th Scientific Sessions. For access to program navigation, educational session information, news updates, abstracts, and exhibitor information, the 2025 ADA Scientific Sessions mobile app and the online planner are your go-to meeting resources.

For more information, please contact the ADA's Scientific Sessions media team at [email protected].

Embargo Policy:

• Oral presentations: Oral presentations are embargoed from the time of submission until the scheduled start of their presentation at the 85^th Scientific Sessions.
• Symposiums (including late-breaking symposiums): Symposiums and presentations within symposiums are embargoed until the beginning of the symposium session at the 85^th Scientific Sessions. 
• Poster presentations (including late-breaking posters): Poster presentations are embargoed from the time of submission until Friday, June 20, 2025, at 6:30 p.m. CT.

About the ADA's Scientific Sessions
The ADA's 85^th Scientific Sessions, the world's largest scientific meeting focused on diabetes research, prevention, and care, will be held in Chicago, IL on June 20-23. Thousands of leading physicians, scientists, and health care professionals from around the world are expected to convene both in person and virtually to unveil cutting-edge research, treatment recommendations, and advances toward a cure for diabetes. Attendees will receive exclusive access to thousands of original research presentations and take part in provocative and engaging exchanges with leading diabetes experts. Join the Scientific Sessions conversation on social media using #ADASciSessions.

About the American Diabetes Association
The American Diabetes Association (ADA) is the nation's leading voluntary health organization fighting to end diabetes and helping people thrive. This year, the ADA celebrates 85 years of driving discovery and research to prevent, manage, treat, and ultimately cure—and we're not stopping. There are 136 million Americans living with diabetes or prediabetes. Through advocacy, program development, and education, we're fighting for them all. To learn more or to get involved, visit us at diabetes.org or call 1-800-DIABETES (800-342-2383). Join us in the fight on Facebook (American Diabetes Association), Spanish Facebook (Asociación Americana de la Diabetes), LinkedIn (American Diabetes Association), and Instagram (@AmDiabetesAssn). To learn more about how we are advocating for everyone affected by diabetes, visit us on X (@AmDiabetesAssn). 

SOURCE American Diabetes Association